Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71,830 ILa | -3.44% | -15.08% | -0.97% |
Sales 2024 * | 2.72B 1,009B | Sales 2025 * | 3.04B 1,127B | Capitalization | 12.69B 4,700B |
---|---|---|---|---|---|
Net income 2024 * | 449M 166B | Net income 2025 * | 548M 203B | EV / Sales 2024 * | 4.12 x |
Net cash position 2024 * | 1.46B 539B | Net cash position 2025 * | 2.25B 834B | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
29.1
x | P/E ratio 2025 * |
22.6
x | Employees | 8,384 |
Yield 2024 * |
0.02% | Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
1 day | -3.20% | ||
1 week | -14.83% | ||
Current month | -14.01% | ||
1 month | -14.58% | ||
3 months | -12.24% | ||
6 months | -0.19% | ||
Current year | -0.68% |
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 14-04-29 |
Darren Rushworth
PSD | President | 56 | 16-12-31 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 16-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 13-07-31 |
David Kostman
CHM | Chairman | 59 | 00-12-31 |
Dan Falk
BRD | Director/Board Member | 79 | 00-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.58% | 17 M€ | +7.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-19 | 71,830 | -3.44% | 64 856 |
24-05-16 | 74,390 | -10.48% | 319,004 |
24-05-15 | 83,100 | -1.71% | 128,009 |
24-05-12 | 84,550 | +2.11% | 25,595 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 19, 2024 at 04:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.68% | 12.64B | |
+11.75% | 3,123B | |
+10.06% | 86.45B | |
+6.04% | 78.6B | |
-14.66% | 53.98B | |
+26.73% | 48.46B | |
-24.44% | 46.78B | |
+31.74% | 46.36B | |
+82.12% | 42.36B | |
-8.15% | 25.25B |
- Stock Market
- Equities
- NICE Stock